Hm Payson & CO Immucell Corp Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Immucell Corp stock. As of the latest transaction made, Hm Payson & CO holds 4,000 shares of ICCC stock, worth $14,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,000

Previous 6,000 33.33%

Holding current value

$14,840

Previous $29,000 51.72%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$3.53 - $4.46 $7,060 - $8,920	-2,000 Reduced 33.33%	4,000 $14,000
Q3 2023 Nov 06, 2023	SELL	$4.53 - $5.61 $27,768 - $34,389	-6,130 Reduced 50.54%	6,000 $32,000
Q2 2023 Jul 17, 2023	BUY	$4.64 - $5.98 $18,560 - $23,920	4,000 Added 49.2%	12,130 $60,000
Q4 2021 Feb 15, 2022	BUY	$8.0 - $9.74 $49,040 - $59,706	6,130 Added 306.5%	8,130 $65,000
Q1 2021 Jun 15, 2021	SELL	$5.98 - $11.88 $110,630 - $219,780	-18,500 Reduced 90.24%	2,000 $19,000
Q4 2020 Mar 10, 2021	SELL	$5.21 - $6.42 $46,890 - $57,780	-9,000 Reduced 30.51%	20,500 $122,000
Q2 2020 Aug 13, 2020	BUY	$3.95 - $4.9 $15,800 - $19,600	4,000 Added 15.69%	29,500 $139,000
Q4 2019 Feb 18, 2020	SELL	$4.81 - $5.57 $4,810 - $5,570	-1,000 Reduced 3.77%	25,500 $131,000
Q3 2019 Nov 12, 2019	SELL	$5.15 - $6.55 $10,300 - $13,100	-2,000 Reduced 7.02%	26,500 $147,000
Q2 2019 Aug 15, 2019	SELL	$5.89 - $6.86 $135,470 - $157,780	-23,000 Reduced 44.66%	28,500 $185,000
Q1 2019 Jul 31, 2019	BUY	$5.91 - $8.09 $304,365 - $416,635	51,500 New	51,500 $327,000

Others Institutions Holding ICCC

# of Institutions

Shares Held

1.15M

Call Options Held

Put Options Held

View Full List

About IMMUCELL CORP

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $28.7M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

More about ICCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account